Supply chain integrity the focus of newly launched Thermo Fisher services for CGT sector

Excerpt: Thermo Fisher Scientific says it is leveraging the company’s global infrastructure to offer end-to-end services aimed at speeding up the introduction of cell and gene therapies. Article Summary: The organization notes that a large number of cell and gene therapies are expected to reach commercialization in the next few years. Like with any biologic, […]

Singapore and Asia’s leading BioPharma Map the Future and Catalyze Recovery for the Biomanufacturing Industry

Singapore, 31st March 2022 – The 9th Annual Biologics Manufacturing Asia 2022 & the 6th Annual BioLogistics World Asia 2022 conferences kicks off with Industry views on post pandemic biomanufacturing and a focus on the future of Asia’s Bioprocessing sector. The annual event gathered biologics and vaccine experts from all over the world at Suntec […]

Novartis Signs Initial Agreement with Carisma Therapeutics for the Manufacturing of HER 2 Targeted CAR-M Cell Therapy

Excerpt Novartis has signed an initial agreement with Carisma Therapeutics (a biopharmaceutical company focusing on engineered macrophage-based therapeutics) to manufacture the HER 2 targeted CAR-M cell therapy, which is tested in initial trials for the treatment of solid tumors. Article Summary Under the terms of the agreement, the Carisma Therapeutics manufacturing process will be transferred […]

UCB to Build Gene Therapy Process Development and Clinical Manufacturing Facility in Belgium

Excerpt UCB has announced the construction of a sustainable gene therapy process development and clinical manufacturing facility on their high-tech campus in Braine l’Alleud, Wallonia, Belgium. The company has plans to invest more than 200 million euros in the facility over the coming years. The facility is expected to be operational in 2024 while its […]

UMass Chan Medical School Developed Muscle Stem Cell Technology

Excerpt UMass Chan Medical School researchers have developed a technique to isolate human skeletal muscle stem cells, also known as progenitor cells, from induced pluripotent stem cells (iPSCs). Researchers can use patient-derived muscle stem cells like iMyoblasts to study at the early effects of disease-causing mutations on muscle development and function in the lab. Article […]

WuXi ATU Launches TESSA™ Technology to Enhance Scalability and Accessibility of Cell & Gene Therapies

Excerpt WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, has announced the launch of Tetracycline-Enabled Self-Silencing Adenovirus (TESSA™). This technology offers a scalable process for transfection-free manufacturing of adeno-associated virus (AAV) at Good Manufacturing Practice (GMP) grade. Developed by OXGENE in the UK, a WuXi Advanced Therapies company, TESSA™ will expedite AAV […]

Abclone and HK Innoen Team Up to Develop an Innovative CAR-T Cell Therapy

Excerpt Abclone announced that it had inked an MOU with HK for cooperative CAR-T cell therapy development. The two businesses will work closely on the commercialization and production of AT101, a type of immunotherapy developed with CAR-T technology (Novel Epitope Screening Technology (NEST) to treat blood cancers expressing CD19. Abclone received an IND for AT101 in […]

EdiGene Entered into a Non-exclusive License Agreement with Arbor to Advance Cell Therapy Programs in Oncology Field

Excerpt EdiGene, Inc., a global biotechnology company engaged in translating gene-editing technologies into transformative therapies for patients with serious genetic diseases and cancer has announced a worldwide non-exclusive license agreement with Arbor Biotechnologies, to access Arbor’s proprietary CRISPR gene-editing technology to advance ex-vivo engineered cell therapy programs in the field of oncology. Article Summary Arbor’s […]

GenEdit and Sarepta to Develop Gene-Editing Therapeutics for Neuromuscular Diseases

Excerpt Sarepta Therapeutics and GenEdit announced a research collaboration and option agreement under which the companies are employing GenEdit’s NanoGalaxy platform and Sarepta’s gene-editing technology to develop gene-editing therapeutics for the treatment of neuromuscular diseases. Article Summary Under the agreement announced on Sarepta obtains exclusive option rights to license polymer nanoparticles developed by GenEdit in […]

Thermo Fisher Unveils New Cell and Gene Therapy Integrated Services

Excerpt The Patheon Commercial Packaging Service for Cell and Gene Therapy is an end-to-end solution that integrates GMP warehousing, serialization, and packaging services, with a global distribution that therapy developers need for their logistics support. It is designed to transition therapies from clinic to commercial launch for patients across the U.S. and Europe. Article Summary […]

ImmunityBio Expands Manufacturing Capacity with State-of-the-Art Manufacturing Plant in New York

Excerpt ImmunityBio, Inc. has signed an agreement with global pharmaceutical company Athenex, Inc. to obtain a leasehold interest in 409,000 square feet of ISO Class 5 pharmaceutical manufacturing space in western New York (the “Dunkirk Facility”), as well as all other related assets. Article Summary ImmunityBio will get a state-of-the-art biotech production facility as part of the […]

Singapore-Based SCG Cell Therapy Acquires iPSC Technology From A*STAR For Cancer Treatment

Excerpt Singapore-based biopharma company, SCG Cell Therapy Pte Ltd, has acquired the rights to human “induced pluripotent stem cell” (iPSC) technology, from the Agency for Science, Technology, and Research (“A*STAR”)’s Accelerate Technologies Pte Ltd (“A*ccelerate”) to develop allogeneic natural killer cell therapy. Article Summary Through this technology, SCG will be able to expand its cell […]